At 9.0% CAGR, the South & Central America Brain Implants Market is Projected to be Worth US$ 730.98 million by 2030, Says Business Market Insights

According to Business Market Insights research, the South & Central America brain implants market was valued at US$ 366.05 million in 2022 and is expected to reach US$ 730.98 million by 2030, registering a CAGR of 9.0% from 2022 to 2030. Technological advancements such as miniaturization, artificial intelligence, and modern brain-machine interfaces and rising number of spinal cord injuries are among the critical factors attributed to the South & Central America brain implants market expansion.

Advancements in technology have led to the development of smaller, more compact brain implants, making them more suitable for noninvasive or minimally invasive surgical procedures. Improved electrode designs, advanced programming algorithms, 3D printing, brain-computer interfaces (BCI), motor neuron prostheses, self-charging implants, memory chips, and miniaturization are a few of the modern trends in the South & Central America brain implants market, which are likely to improve the effectiveness of treatments. These innovations provide patients with greater customization, adaptability, and other long-term benefits. In addition to the development of smaller and more flexible implants, advancements in wireless communication and power delivery systems can enhance the functionality and usability of brain implants. By reducing the invasiveness and improving the user experience, these advancements can expand the potential applications of brain implants and attract a broader patient population. Furthermore, these advancements benefit patients who require long-term implants, as smaller devices can lower the risk of complications and allow for easier placement and removal.

The integration of artificial intelligence (AI) and machine learning algorithms can further optimize the performance of brain implants by enabling personalized therapies and real-time adaptive stimulation. AI-powered neural implants have the potential to improve patients' quality of life, particularly those suffering from Alzheimer's disease. Recent research indicates that AI-powered brain-machine interfaces can effectively identify and track the progression of Alzheimer's, leading to earlier diagnosis and intervention. Innovations in BCI technology have provided new ways for communication and control for individuals with severe disabilities. BCIs can enable individuals with locked-in syndrome or spinal cord injuries to interact with their surroundings using their thoughts. These implants can decode neural signals and translate them into commands for external devices, such as prosthetic limbs or computer interfaces.

Companies such as Medtronic, Neuropace, and St. Jude Medical are developing systems to actively monitor brain activity. Some monitoring systems are used in conjunction with other assistive devices, such as robotic aids, to help patients suffering from neurological disorders to regain lost motor function.

On the contrary, high cost associated with brain implant devices and procedures hampers the growth South & Central America brain implants market.

Based on treatment, the South & Central America brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain-computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. The spinal cord stimulation segment held 37.5% share of the South & Central America brain implants market in 2022, amassing US$ 137.30 million. It is projected to garner US$ 187.92 million by 2030 to expand at 4.0% CAGR during 2022-2030. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment. The spinal cord stimulation segment held the largest share in 2022.

Based on application, the South & Central America brain implants market is categorized into chronic pain, Parkinson's disease, Alzheimer's disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held 38.5% share of the South & Central America brain implants market in 2022, amassing US$ 140.76 million. It is projected to garner US$ 269.23 million by 2030 to expand at 8.4% CAGR during 2022-2030.

Based on end user, the South & Central America brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held 72.0% share of the South & Central America brain implants market in 2022, amassing US$ 263.66 million. It is projected to garner US$ 559.41 million by 2030 to expand at 9.9% CAGR during 2022-2030

Based on country, the South & Central America brain implants market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil held 58.7% share of South & Central America brain implants market in 2022, amassing US$ 214.84 million. It is projected to garner US$ 441.65 million by 2030 to expand at 9.4% CAGR during 2022-2030.

Key players operating in the South & Central America brain implants market are Abbott Laboratories, Boston Scientific Corp, Medtronic Plc, and Renishaw Plc, among others.

• In June 2023; Boston Scientific Corp received US Food and Drug Administration (FDA) approval for the Vercise Neural Navigator 5 Software, which when used as part of the Vercise Genus Deep Brain Stimulation (DBS) Systems. It provides clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson's disease or essential tremor.
  
  
  Contact Us
  Phone: +16467917070
  Email Id: sales@businessmarketinsights.com